Filters
Study Phase
Recruitment Status
Study Type
Eligibility Sex
Healthy Volunteers
Found 540544 clinical trials
Sort by:
MEnstrual Cycle pHase ANd dIabeteS Management
Completed
- Conditions
- Type 1 Diabetes Mellitus
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- DCB Research AG
- Target Recruit Count
- 82
- Registration Number
- NCT07004504
- Locations
- 🇨🇭
DCB Research AG, Bern, Switzerland
A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Malignant Brain Tumors
Phase 1
Not yet recruiting
- Conditions
- Malignant Brain Tumors
- Interventions
- Drug: B10 L-BPA Injection
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT07003139
Effectiveness of Corticosteroid and 5% Dextrose Versus USG-guided Ozone Injections in Patients With Carpal Tunnel Syndrome: Three Blind Randomized Studies
Not Applicable
Recruiting
- Conditions
- Carpal Tunnel Syndrome Treatment
- Interventions
- Drug: Ozon treatmentDrug: Dextrose 5%Drug: Steroid treatment
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Yunus Burak Bayır
- Target Recruit Count
- 72
- Registration Number
- NCT07002892
- Locations
- 🇹🇷
Ankara Etlik City Hospital, Ankara, Turkey
Effect of MGRNOX Index-Guided General Anesthesia on Opioid Consumption in Patients
Not Applicable
Recruiting
- Conditions
- Opioid Use
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Peking University Shenzhen Hospital
- Target Recruit Count
- 112
- Registration Number
- NCT07004686
- Locations
- 🇨🇳
Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
the MCCE vs EGD Trial
Not Applicable
Not yet recruiting
- Conditions
- AnaemiaAcute Coronary Syndrome
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 238
- Registration Number
- NCT07004530
- Locations
- 🇭🇰
Prince of Wales Hospital, Hong Kong, Shatin, Hong Kong
Application of Remimazolam Combined With Esketamine in Painless Gastroscopy and Colonoscopy in Elderly Patients
Not Applicable
Recruiting
- Conditions
- Gastrointestinal Disease
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Harbin Medical University
- Target Recruit Count
- 280
- Registration Number
- NCT07002801
- Locations
- 🇨🇳
The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China
Therapy of Niacin for Rheumatoid Arthritis
Phase 2
Not yet recruiting
- Conditions
- Rheumatoid Arthritis (RA)
- Interventions
- Drug: niacin sustained release capsulesDrug: Placebo
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT07004725
A Research Study of the New Medicine NNC0519-0130 in Male Chinese Participants Living With Excess Body Weight
Phase 1
Not yet recruiting
- Conditions
- Diabetes Mellitus, Type 2Obesity
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 20
- Registration Number
- NCT07004322
- Locations
- 🇨🇳
Peking University Third Hospital, Northern branch-Phase I, Beijing, Beijing, China
PULSE PVC Registry: Multicenter Study on Focal Pulsed Field Ablation for Premature Ventricular Contractions
- Conditions
- Pulsed Field AblationPremature Ventricular Contraction (PVC)
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Zentralklinik Bad Berka
- Target Recruit Count
- 200
- Registration Number
- NCT07003412
- Locations
- 🇩🇪
Zentralklinik Bad Berka, Bad Berka, Thüringen, Germany
Evaluating the Efficacy and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) for the Treatment of Flank Fat
Not Applicable
Completed
- Conditions
- Flank Fat
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Espad Pharmed
- Target Recruit Count
- 30
- Registration Number
- NCT07004010
- Locations
- 🇮🇷
Orchid Pharmed, Medical Department, Tehran, Iran, Islamic Republic of
© Copyright 2025. All Rights Reserved by MedPath